Medical Devices: Page 13


  • A watch that says parky next to a smartphone, with another watch on the right.
    Image attribution tooltip
    Courtesy of H2O Therapeutics
    Image attribution tooltip

    FDA seeks AI tech to predict, detect Parkinson’s symptoms

    By testing artificial intelligence and machine learning models, the agency hopes to come up with best practices for Parkinson’s measures from wearables and smartphones.

    By May 21, 2024
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic heads into earnings having seen rivals prosper

    J.P. Morgan and RBC analysts are expecting updates on several key markets on Medtronic's Q4 call, including surgical robotics and pulsed field ablation.

    By May 21, 2024
  • Front sign of FDA building Explore the Trendline
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Medical device safety in spotlight after high profile recalls

    From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.

    By MedTech Dive staff
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific’s cardiac rhythm system hits pivotal trial goals

    Boston Scientific, which presented the results at the Heart Rhythm Society meeting, expects to receive FDA approval for the system in 2025.

    By May 21, 2024
  • A catheter has a spiral wire with a hook at the tip
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Pulsed field ablation poised for fast adoption, analysts say

    Feedback from the Heart Rhythm Society meeting suggests 50% to 70% of physicians could adopt the procedure “right out of the gate,” said Truist analyst Richard Newitter.

    By May 20, 2024
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    UK backs use of cancer treatment offered by Boston Scientific

    A Boston Scientific executive said the guidance will expand access to a minimally invasive treatment for tumors that have metastasized to the liver.

    By May 20, 2024
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J posts latest Varipulse data while awaiting FDA review

    Johnson & Johnson is chasing Medtronic and Boston Scientific in the U.S. for a share of the rapidly growing pulsed field ablation market.

    By May 20, 2024
  • new cfo appointments dell, warner, qurate
    Image attribution tooltip
    Getty Images via Getty Images
    Image attribution tooltip

    Pulse Biosciences names new CEO, reassigns former leader

    Burke Barrett will take over the role effectively immediately, while former CEO Kevin Danahy will become the chief commercial officer.

    By May 17, 2024
  • the FDA Headquarters
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip

    FDA issues import alerts against 2 more plastic syringe manufacturers

    Officials moved to stop the plastic syringes made by two Chinese manufacturers from entering the U.S. after finding quality system failings.

    By May 17, 2024
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson
    Image attribution tooltip

    BD wins FDA approval for cervical cancer screening self-collection kit

    Patients can self-collect the samples in locations such as retail pharmacies, which could encourage more people to get tested.

    By May 17, 2024
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage

    Diabetes tech companies shared updates on new products, largely focused on Type 2 patients, in Q1 earnings calls.

    By May 16, 2024
  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    Getinge to limit US sales of heart devices after FDA safety warning

    CEO Mattias Perjos said the action will have “some negative financial impact,” but the total effect will depend on customers' response.

    By May 16, 2024
  • Two wooden blocks on a computer keyboard that spell out "M&A"
    Image attribution tooltip
    Maks_Lab via Getty Images
    Image attribution tooltip

    Stereotaxis inks APT buyout to gain catheters for surgical robots

    The partners are developing a robotically steered diagnostic catheter for use with Stereotaxis’ cardiovascular robots.

    By May 16, 2024
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific recalls more than 1M angiographic catheters

    Hospitals should discontinue use of the devices and return them due to potential safety risks, Boston Scientific wrote in a March letter to customers.

    By May 15, 2024
  • Abbott HeartMate 3 left ventricular assist device
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott recalls Heartmate pump after 70 injuries, 2 deaths reported

    In the latest notice, which follows a February recall of the device for a separate issue, Abbott took action due to reports of blood leakage and air entrapment.

    By Updated May 16, 2024
  • A picture of U.K. Prime Minister Rishi Sunak and Chancellor of the Exchequer Jeremy Hunt during a visit at Siemens Healthineers in Oxfordshire.
    Image attribution tooltip
    Courtesy of Simon Dawson / 10 Downing Street
    Image attribution tooltip

    Siemens Healthineers invests $314M in new MRI manufacturing plant

    Siemens said the facility will support 1,300 jobs, including the more than 600 people it currently employs in the area.

    By May 15, 2024
  • A person stands in front of the screen of a machine on wheels, near a sign that says "GE HealthCare"
    Image attribution tooltip
    Stringer via Getty Images
    Image attribution tooltip

    GE Healthcare warns of cybersecurity risks in ultrasound devices, software

    Cybersecurity group Nozomi Networks Labs identified 11 vulnerabilities across several systems and software in an investigation of imaging machines.

    By May 15, 2024
  • A facade of the White House in Washington, D.C.
    Image attribution tooltip
    Nick van Bree via Getty Images
    Image attribution tooltip

    US hikes tariffs on medical products from China

    The rate increases will apply to equipment including syringes, face masks and surgical gloves.

    By Updated May 14, 2024
  • A picture of Pacific Biosciences San Diego building.
    Image attribution tooltip
    Courtesy of Pacific Biosciences
    Image attribution tooltip

    Pacific Biosciences to lay off 195 employees as part of cost cuts

    More than half of the job losses stem from the closure of the genome sequencer’s San Diego office amid an ongoing industry slump.

    By May 14, 2024
  • Overhead view of brick, multistory buildings along a one-way street.
    Image attribution tooltip
    deberarr via Getty Images
    Image attribution tooltip

    FDA targets health inequality by improving at-home devices

    Michelle Tarver, an FDA official, said a new program is meant to advance health equity by considering people’s living conditions as part of medical device design.

    By May 13, 2024
  • J&J HQ
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J’s Megadyne discontinues pediatric electrode pad after burn reports

    Megadyne discontinued the product globally after receiving four reports of patients being burned in procedures when the electrode pads were used.

    By May 13, 2024
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Route 92 catheter recall tied to 2 injuries, 1 death

    The affected devices were manufactured by an outside supplier, not Route 92, and had product quality problems.

    By May 13, 2024
  • Masimo CEO Joe Kiani looks over the countryside
    Image attribution tooltip
    Courtesy of BusinessWire/Masimo
    Image attribution tooltip

    Masimo offers Politan a concession to avoid second proxy fight

    Activist investor Politan immediately snubbed Masimo’s offer to accept one nominee to its board, insisting two new directors are needed to resolve governance issues at the pulse oximetry specialist.

    By May 10, 2024
  • Close-up of a sign with office building and trees in background
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts final guidance on remanufacturing medical devices

    Nearly three years after publishing draft guidance, the FDA has changed the title and added a section on the regulatory requirements for remanufacturers in the final version of the text.

    By May 10, 2024
  • How stricter EtO regs could shape the medtech industry

    In April, the EPA issued a final rule that would limit emissions of ethylene oxide from device sterilizers. The FDA is also taking actions to help reduce emissions of the toxic sterilant.

    By May 10, 2024
  • A headshot of Jennifer Jones-McMeans, who is smiling in the photo. She is wearing an orange blouse and blue hoop earrings.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott’s Jennifer Jones-McMeans on treating PAD below the knee

    Jennifer Jones-McMeans, a leader in Abbott’s vascular unit, discussed the company’s newly approved stent for the tough-to-treat condition in an interview with MedTech Dive.

    By May 9, 2024